DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice

The outbreak of the SARS-CoV-2 virus and its rapid spread into a global pandemic made the urgent development of scalable vaccines to prevent coronavirus disease (COVID-19) a global health and economic imperative. Here, we characterized and compared the immunogenicity of two alphavirus-based DNA-laun...

Descripción completa

Detalles Bibliográficos
Autores principales: Szurgot, Inga, Hanke, Leo, Sheward, Daniel J., Vidakovics, Laura Perez, Murrell, Ben, McInerney, Gerald M., Liljeström, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862230/
https://www.ncbi.nlm.nih.gov/pubmed/33542325
http://dx.doi.org/10.1038/s41598-021-82498-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862230/
https://www.ncbi.nlm.nih.gov/pubmed/33542325
http://dx.doi.org/10.1038/s41598-021-82498-5

Ejemplares similares